Related Experiment Video

Updated: Mar 3, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

MicroRNA-134 targets KRAS to suppress breast cancer cell proliferation, migration and invasion

Xiaomei Su1, Ling Zhang1, Hua Li1

  • 1Department of Oncology, Chengdu Military General Hospital, Chengdu, Sichuan 610083, P.R. China.

Oncology Letters
|April 30, 2017
PubMed

Insights

MicroRNA-134 (miR-134) is downregulated in breast cancer, inhibiting tumor growth and metastasis. This study suggests miR-134 could serve as a therapeutic biomarker for breast cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-134 (miR-134) functions are known in various cancers, but its role in human breast cancer remains uninvestigated.
  • Understanding miR-134's expression and function is crucial for developing novel breast cancer therapies.

Purpose of the Study:

  • To investigate the expression patterns, biological functions, and molecular mechanisms of miR-134 in human breast cancer.
  • To determine the potential of miR-134 as a diagnostic or therapeutic biomarker for breast cancer.

Main Methods:

  • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) to assess miR-134 expression in tissues and cell lines.
  • In vitro assays (MTT, migration, invasion) and western blot analysis in MCF-7 and MDA-MB-231 cells following miR-134 transfection.
  • Luciferase assay to identify potential molecular targets of miR-134.

Main Results:

  • miR-134 expression was significantly downregulated in human breast cancer tissues and cell lines compared to normal controls.
  • Low miR-134 expression correlated with lymph node metastasis, advanced TNM stage, and reduced cell differentiation.
  • Overexpression of miR-134 suppressed breast cancer cell proliferation, migration, and invasion.
  • miR-134 was found to directly target Kirsten rat sarcoma viral oncogene homolog (KRAS).

Conclusions:

  • miR-134 acts as a tumor suppressor in human breast cancer by inhibiting cell growth, migration, and invasion.
  • The downregulation of miR-134 and its targeting of KRAS suggest its potential as a therapeutic biomarker.
  • Further research into miR-134 could lead to novel therapeutic strategies for breast cancer.
Keywords:
Kirsten rat sarcoma viral oncogene homologbreast cancermicroRNA-134therapy

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

828

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K